Guest column: Non-surgical therapy to treat brain tumors

Brain tumour is one of the most aggressive forms of malignant tumors and the survival period for a patient is mostly 14 months. Every year about 8,50,000 new cancer cases are diagnosed in India, of which 5,80,000 cancers result in death. More than 60% of these affected patients are in the prime of their life between the ages of 35 and 65 years.

The standard treatment options of cancer include surgery, chemotherapy and radiotherapy which mostly result in partial cure with multiple side effects, deterioration of quality of life which further compounds the emotional and psychological distress associated with cancer patients.

Glioblastoma Multiforme (GBM) is one of the most common type of brain tumors that are known to occur majorly in adults and also in children to some extent. Despite the variety of treatment options available today, malignant gliomas consistently remain a high-mortality disease characterized by a swift and disastrous clinical progression.

Sequentially Programmed Magnetic Field (SPMF) Therapypioneered and patented by Dr. V G Vasishta have successfully saved and revived lives of over 500 brain tumor cancer patients.With SPMF Therapy, such patients have been treated successfully who have survived for more than five years on average.

SPMF is a unique type of treatment that is non-invasive and safe, painless, affordable, scientifically proven and most effective treatment for brain tumor. A patient’s condition is evaluated using MRI and the Karnofsky Performance Score (KPS) which are the gold standards for evaluating the efficacy of a therapy. This treatment is administered through an advanced medical device called AKTIS SOMA. This therapy is conducted over a 28-day period (one hour a day).

SPMF is a non-surgical treatment that helps degenerate cells in cancer. It has proved to be effective in the treatment of different types of cancer. This technology produces highly complex sequentially programmed magnetic fields, which are computer-controlled and can be precisely focused on to the target tissues with the help of laser guides.

—The author, Wing Cdr (Dr.) V. G. Vasishta, is a Founder & Chairman, SBF Healthcare.